
Company News
Investors must take note of Galectin Therapeutics Inc’s (GALT) performance last week, which was 32.56%.
Galectin Therapeutics Inc (NASDAQ: GALT) kicked off on Monday, up 13.55% from the previous trading day, before settling in for the closing price of $2.51.